InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Hassanein Waleed H, Chairman & CEO. Officer active across 1 companies, notably TransMedics Group, Inc.. In total, 2 reports have been published. The latest transaction was filed on 6 January 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€30,286122,371 shares@ €0.24750.0007% mcap100.0% of flow
Common Stock
SEC:0000899243-22-001372·
€30,286122,371 shares@ €0.24750.0007% mcap50.0% of flow
Common Stock
SEC:0000899243-22-001372:0·
2 of 2 declarations
About Hassanein Waleed H
Waleed H. Hassanein is the Chief Executive Officer of TransMedics Group, Inc. In this role, he leads the company's operations and strategy in the medical technology field. His expertise in this sector enables him to drive innovative initiatives to improve healthcare.
